Status:

WITHDRAWN

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

Lead Sponsor:

University of Vermont

Conditions:

Hepatitis C

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Chronic hepatitis C is a major cause of liver disease and is thus an important public health problem. Although some strains (genotypes) of the hepatitis C virus are highly responsive to treatment with...

Detailed Description

Chronic infection with the hepatitis C virus (HCV), which affects 1-2% of adults in the United States, is a major risk factor for liver failure due to cirrhosis and/or hepatocellular carcinoma (Davis ...

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Serum Hepatitis C RNA \> 10,000IU/mL
  • Hepatitis C virus genotype 1
  • IL28B polymorphism

Exclusion

  • Previous treatment for chronic Hepatitis C
  • clinical or biological evidence of acute hepatitis, including serum ALT or AST \> 300U/ml
  • HIV antibody positive, hepatitis b surface antigen positive or known diagnosis of other chronic liver disease
  • Contraindications to PR-based treatment:
  • uncontrolled psychiatric illness
  • active substance dependency
  • Known autoimmune disorder
  • Untreated thyroid disease
  • Uncontrolled seizure disorder
  • Pregnancy, lactation or inability to maintain contraception
  • Chronic kidney disease w/ estimated GFR\< 60
  • ANC\<1.5/nl, Hb\<12g/dl, or platelets\<75/nl
  • Clinical or biochemical evidence of decompensated liver disease including:
  • History of encephalopathy, ascites, or variceal bleeding OR
  • Bilirubin \> 3g/dl or INR \> 1.5
  • Life threatening disorder with expected median survival less than 5 years
  • Inability to comply with drug regimens or testing schedule required for study
  • Lack of insurance coverage for any of the study medications

Key Trial Info

Start Date :

July 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01415141

Start Date

July 1 2011

End Date

July 1 2011

Last Update

May 9 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Emory University School of Medicine

Atlanta, Georgia, United States, 30030

2

Fletcher Allen Health Care

Burlington, Vermont, United States, 05401